Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma | MicrobiomeTrials
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2028-03
Enrollment target: 56 participants
Locations
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Other microbiome trials you might be interested in